Early-morning OFF and levodopa dose failures in patients with Parkinson's disease attending a routine clinical appointment using Time-to-ON Questionnaire

Eur J Neurol. 2019 May;26(5):821-826. doi: 10.1111/ene.13895. Epub 2019 Jan 28.

Abstract

Background and purpose: In patients with Parkinson's disease (PD) with motor fluctuations, total daily OFF time is comprised of both end-of-dose time and the time taken to turn ON with medication. However, little is known about the impact of delays in ON time.

Methods: This was a single-visit pilot study of fluctuating patients with PD attending a routine appointment. During a single visit, adult patients with idiopathic PD who were treated with levodopa for at least 1 year completed a questionnaire evaluating the time waiting for ON and the symptoms experienced while waiting to turn ON. Patients then completed a 5-day home time-to-ON diary, where they documented how long it took to turn ON following their first morning dose of levodopa in 5-min increments.

Results: A total of 151 consecutive patients completed the study survey, of whom 97 (64.2%) experienced motor fluctuations. Of the patients experiencing motor fluctuations, 54 (56%) reported delays in ON time (latency >30 min) following their first morning dose of levodopa. Half (51%) reported that they had experienced delayed ON at least once in the previous week and 21% reported having delayed ON during all seven mornings of the previous week. In addition, 10% of patients reported having dose failures on four or more mornings during the previous week. The most common symptoms experienced while waiting for ON were slowness (94.8%), fatigue (87.6%), reduced dexterity (82.5%), problems in walking (66.0%) and problems with balance (59.8%).

Conclusion: Early-morning OFF problems such as delays in time to ON and dose failures are common in levodopa-treated patients with PD.

Keywords: OFF; ON-OFF; Parkinson's disease; delayed ON; early-morning akinesia; motor fluctuations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / administration & dosage*
  • Antiparkinson Agents / therapeutic use*
  • Appointments and Schedules
  • Drug Administration Schedule
  • Female
  • Humans
  • Levodopa / administration & dosage*
  • Levodopa / therapeutic use*
  • Male
  • Middle Aged
  • Movement Disorders / drug therapy
  • Movement Disorders / physiopathology
  • Parkinson Disease / drug therapy*
  • Pilot Projects
  • Surveys and Questionnaires*
  • Treatment Failure

Substances

  • Antiparkinson Agents
  • Levodopa